RELAPSING - REMITTING MULTIPLE SCLEROSIS
Clinical trials for RELAPSING - REMITTING MULTIPLE SCLEROSIS explained in plain language.
Never miss a new study
Get alerted when new RELAPSING - REMITTING MULTIPLE SCLEROSIS trials appear
Sign up with your email to follow new studies for RELAPSING - REMITTING MULTIPLE SCLEROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a tiny neck implant help repair MS-damaged nerves?
Disease control Recruiting nowThis study tests a small device implanted on the vagus nerve in the neck to see if it can help repair myelin (the protective coating around nerves) in people with relapsing-remitting multiple sclerosis. About 60 adults aged 22–50 will take part. Two-thirds will receive active sti…
Matched conditions: RELAPSING - REMITTING MULTIPLE SCLEROSIS
Phase: NA • Sponsor: SetPoint Medical Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Engineered immune cells take on multiple sclerosis and other autoimmune brain diseases
Disease control Recruiting nowThis early-phase study tests a new treatment called RD06-05, which uses specially engineered immune cells (CAR-T cells) to target and calm the immune system in people with neurological autoimmune diseases like multiple sclerosis, myasthenia gravis, chronic inflammatory demyelinat…
Matched conditions: RELAPSING - REMITTING MULTIPLE SCLEROSIS
Phase: EARLY_PHASE1 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Cheaper MS drug could match costly standard in new trial
Disease control Recruiting nowThis phase 3 trial tests whether rituximab, a less expensive drug, works as well as ocrelizumab for people with relapsing-remitting multiple sclerosis. About 386 participants will receive either drug and be followed for 2 years. The main goal is to see if rituximab can keep the d…
Matched conditions: RELAPSING - REMITTING MULTIPLE SCLEROSIS
Phase: PHASE3 • Sponsor: Rennes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Could a stem cell transplant tame Hard-to-Control MS?
Disease control Recruiting nowThis study compares a stem cell transplant (using a person's own cells) against the best available medications for people with relapsing multiple sclerosis that hasn't responded to treatment. About 156 participants will be randomly assigned to one of the two approaches and follow…
Matched conditions: RELAPSING - REMITTING MULTIPLE SCLEROSIS
Phase: PHASE3 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Gut health boost: could probiotics help control MS?
Disease control Recruiting nowThis study tests whether taking a daily probiotic supplement for six months can improve immune function in people with relapsing-remitting multiple sclerosis (MS). Eighty adults aged 18-55 will be randomly assigned to receive either the probiotic or a placebo, alongside their usu…
Matched conditions: RELAPSING - REMITTING MULTIPLE SCLEROSIS
Phase: NA • Sponsor: Hospital Universitari Vall d'Hebron Research Institute • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Cancer drug ixazomib tested as potential MS treatment
Disease control Recruiting nowThis phase 1b trial is testing whether ixazomib, a drug already used for multiple myeloma, is safe for people with multiple sclerosis. The study will enroll 72 adults with relapsing-remitting or progressive MS. Participants will receive either ixazomib or a placebo for up to 24 m…
Matched conditions: RELAPSING - REMITTING MULTIPLE SCLEROSIS
Phase: PHASE1 • Sponsor: Queen Mary University of London • Aim: Disease control
Last updated Jun 26, 2026 13:46 UTC
-
Could a gentle brain zap ease MS fatigue?
Symptom relief Recruiting nowThis study tests whether a mild electrical current applied to the front of the brain for 20 minutes a day over five days can reduce central fatigue in people with relapsing-remitting multiple sclerosis. Researchers will use brain scans and blood tests to see if the stimulation ch…
Matched conditions: RELAPSING - REMITTING MULTIPLE SCLEROSIS
Phase: NA • Sponsor: Charite University, Berlin, Germany • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
MS balance breakthrough? scientists probe Spine's role
Knowledge-focused Recruiting nowThis study examines how spinal posture and movement relate to balance in 30 adults with relapsing-remitting multiple sclerosis. Researchers will measure spinal angles and mobility, then compare them with balance tests. The goal is to identify links that could inform future rehabi…
Matched conditions: RELAPSING - REMITTING MULTIPLE SCLEROSIS
Sponsor: Ankara Yildirim Beyazıt University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Childhood trauma's hidden toll on MS revealed in new study
Knowledge-focused Recruiting nowThis study looks at how difficult childhood experiences might impact the course of multiple sclerosis (MS). Researchers will work with 300 young adults with relapsing-remitting MS, focusing on Black, Hispanic, and low-income groups often left out of research. Participants will ha…
Matched conditions: RELAPSING - REMITTING MULTIPLE SCLEROSIS
Sponsor: NYU Langone Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
MS mystery: why does inflammation smolder even after treatment?
Knowledge-focused Recruiting nowThis observational study at Washington University will use special PET scans to look at ongoing inflammation in the brains of 25 people with relapsing-remitting multiple sclerosis. Researchers want to understand why inflammation persists even after standard treatment. Participant…
Matched conditions: RELAPSING - REMITTING MULTIPLE SCLEROSIS
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
MS study probes hidden nerve damage to improve daily life
Knowledge-focused Recruiting nowThis study looks at how multiple sclerosis affects the autonomic nervous system, which controls automatic body functions like heart rate and sweating. Researchers will use skin biopsies and heart tests to measure nerve damage in 60 people with relapsing-remitting or primary progr…
Matched conditions: RELAPSING - REMITTING MULTIPLE SCLEROSIS
Phase: NA • Sponsor: Istituti Clinici Scientifici Maugeri SpA • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
New brain scan technique could reveal hidden inflammation in MS patients
Knowledge-focused Recruiting nowThis study uses a special PET-MRI scan to measure brain inflammation in people with multiple sclerosis (MS). Researchers will scan 41 adults with active MS and compare the results to healthy volunteers. The goal is to better understand inflammation patterns and improve how we pre…
Matched conditions: RELAPSING - REMITTING MULTIPLE SCLEROSIS
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC
-
New brain scans aim to spot inflammation in MS and Alzheimer's
Knowledge-focused Recruiting nowThis study uses special PET scans to look for brain inflammation in people with multiple sclerosis (MS) and Alzheimer's disease. Researchers will compare two radioactive tracers, [F-18]PBR06 and [C-11]PBR28, to see which works better. Up to 250 participants, including healthy vol…
Matched conditions: RELAPSING - REMITTING MULTIPLE SCLEROSIS
Phase: PHASE1, PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
New app and MRI tool aim to improve MS care
Knowledge-focused Recruiting nowThis study tests a digital platform that combines an app for patients and a brain-scan analysis tool for doctors. The goal is to see if it helps monitor multiple sclerosis (MS) more easily in everyday care. About 500 people with relapsing-remitting MS will use the app and have th…
Matched conditions: RELAPSING - REMITTING MULTIPLE SCLEROSIS
Sponsor: Hoffmann-La Roche • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
New brain scan study aims to improve MS diagnosis and monitoring
Knowledge-focused Recruiting nowThis study looks at how the brain uses sugar (glucose) in people with multiple sclerosis (MS) compared to healthy volunteers. Researchers will use a special PET scan to measure brain activity and compare it with MRI scans and blood tests. The goal is to find better ways to diagno…
Matched conditions: RELAPSING - REMITTING MULTIPLE SCLEROSIS
Phase: PHASE4 • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
Exercise and naps may boost brain training in MS patients
Knowledge-focused Recruiting nowThis study tests whether a short burst of aerobic exercise on a stationary bike and a 30-minute nap can improve how people with multiple sclerosis learn and remember a hand motor skill. Twenty adults with relapsing-remitting MS will take part. Researchers will measure brain and m…
Matched conditions: RELAPSING - REMITTING MULTIPLE SCLEROSIS
Phase: NA • Sponsor: Zealand University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
Gut bacteria linked to brain changes in Alzheimer's, Parkinson's, and MS
Knowledge-focused Recruiting nowThis observational study looks at how gut bacteria relate to brain structure and function in healthy aging and in people with early Alzheimer's, Parkinson's, or multiple sclerosis. Researchers will use brain scans, stool samples, blood tests, and cognitive assessments in 200 part…
Matched conditions: RELAPSING - REMITTING MULTIPLE SCLEROSIS
Sponsor: IRCCS San Camillo, Venezia, Italy • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
Scientists use novel PET tracer to peer into brains of progressive MS patients
Knowledge-focused Recruiting nowThis study aims to understand how brain connections (synapses) are lost in progressive multiple sclerosis (MS). Researchers will use a new type of PET scan to measure synaptic density in 30 people with progressive MS, relapsing-remitting MS, and healthy volunteers. The goal is to…
Matched conditions: RELAPSING - REMITTING MULTIPLE SCLEROSIS
Phase: EARLY_PHASE1 • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
Which MS drug strategy works best for older adults? new study aims to find out
Knowledge-focused Recruiting nowThis study looks at two ways to treat multiple sclerosis (MS) when it first appears after age 50. One approach starts with a moderate-strength drug and only switches to a stronger one if needed. The other starts with a strong drug right away. Researchers will compare how often re…
Matched conditions: RELAPSING - REMITTING MULTIPLE SCLEROSIS
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Brain shrinkage in MS: new study aims to compare treatment effectiveness
Knowledge-focused Recruiting nowThis study follows 400 people with relapsing-remitting multiple sclerosis to see how their brains change over three years. Researchers will use MRI scans and blood tests to compare those on high-efficacy treatments versus medium-efficacy ones. The goal is to understand which trea…
Matched conditions: RELAPSING - REMITTING MULTIPLE SCLEROSIS
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:19 UTC
-
Scientists probe 'Durable Effect' of MS drugs on immune system
Knowledge-focused Recruiting nowThis study follows 100 people with relapsing-remitting multiple sclerosis who are taking anti-CD20 drugs like ofatumumab or rituximab. Researchers will track changes in immune cells, proteins, and brain scans over time to understand how these therapies work long-term. The goal is…
Matched conditions: RELAPSING - REMITTING MULTIPLE SCLEROSIS
Sponsor: Heinrich-Heine University, Duesseldorf • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:42 UTC